WEBINAR
From Vision to Strategy!
Refine Your Early-Stage Drug Screening
Learn a transformative approach that will help you slash costs and accelerate preclinical drug screenings , while increasing success rates in your predictions.
Efficiently screen compounds in vivo in weeks, not months
Gain actionable insights earlier to optimize hit selection before expensive mammalian testing
Improve the relevance of preclinical data to clinical outcomes
Model previously hard-to-study diseases with ease
WEBINAR
From Vision to Strategy!
Refine Your Early-Stage Drug Screening
Learn a transformative approach that will help you slash costs and accelerate preclinical drug screenings, while increasing success rates in your predictions.
Efficiently screen compounds in vivo in weeks, not months
Gain actionable insights earlier to optimize hit selection before expensive mammalian testing
Improve the relevance of preclinical data to clinical outcomes
Model previously hard-to-study diseases with ease
Why You Can't Miss This Webinar
The Challenge in Drug Development:
The pharmaceutical and biotech industries face a daunting reality:
Preclinical costs ranging between $1 - $6 million
1 to 6 years of preclinical development
Only ~10% of drug candidates successfully transition from preclinical to clinical trials
Inefficient Practices Holding You Back:
Jumping directly from in vitro assays to mammalian models like rodents.
Relying exclusively on mammalian models for preclinical development.
A Paradigm Shift is Needed:
There’s a growing movement toward incorporating more predictive and efficient early-stage testing methods. This shift aims to tackle the high failure rates linked to traditional models, which often provide limited insights from in vitro studies and rely on small sample sizes.
Discover a Proven Method:
Join us to learn how to transform your early-stage screening process to achieve:
Actionable Insights Early On
Stronger Statistical Power
Significant Time and Cost Savings
Reduction in Animal Use
Why You Can't Miss This Webinar
Small Call to Action Headline
The pharmaceutical and biotech
industries face a daunting reality:
Preclinical costs ranging between $1 - $6 million
1 to 6 years of preclinical development
Only ~10% of drug candidates successfully transition from preclinical to clinical trials
Inefficient Practices Holding You Back:
Jumping directly from in vitro assays to mammalian models like rodents.
Relying exclusively on mammalian models for preclinical development.
A Paradigm Shift is Needed:
There’s a growing movement toward incorporating more predictive and efficient early-stage testing methods. This shift aims to tackle the high failure rates linked to traditional models, which often provide limited insights from in vitro studies and rely on small sample sizes.
Discover a Proven Method:
Join us to learn how to transform your early-stage screening process to achieve:
Actionable Insights Early On
Stronger Statistical Power
Significant Time and Cost Savings
Reduction in Animal Use
Who Are We?
ZeClinics, Pioneers in Accelerating Drug Discovery
With over a decade of experience, ZeClinics has established itself as a leader in the preclinical drug discovery space, offering cutting-edge preclinical models to biotech and pharma companies globally. Our platform is trusted by 150+ clients in diverse therapeutic areas, from ophthalmology to neurological diseases, helping them achieve faster, more reliable results.
What Set Us Apart:
Unmatched Expertise:
Our team of scientists and genetic engineers has over 40+ years of combined experience and has conducted 300+ successful preclinical studies using tailored-made models.
Proven Results:
Our clients have experienced up to 60% cost savings in their early preclinical trials and reduced timelines by over 40%, accelerating their drug development processes.
Global Recognition:
ZeClinics is proud to collaborate with top-tier institutions, and our models have been highlighted in 20+ peer-reviewed publications, demonstrating their reliability and relevance in translational research.
Who Are We?
ZeClinics, Pioneers in Accelerating Drug Discovery
With over a decade of experience, ZeClinics has established itself as a leader in the preclinical drug discovery space, offering cutting-edge preclinical models to biotech and pharma companies globally. Our platform is trusted by 150+ clients in diverse therapeutic areas, from ophthalmology to neurological diseases, helping them achieve faster, more reliable results.
What Set Us Apart:
Unmatched Expertise:
Our team of scientists and genetic engineers has over 40 years of combined experience and has conducted 300+ successful preclinical studies using tailored-made models.
Proven Results:
Our clients have experienced up to 60% cost savings in their early preclinical trials and reduced timelines by over 40%, accelerating their drug development processes.
Global Recognition:
ZeClinics is proud to collaborate with top-tier institutions, and our models have been highlighted in 20+ peer-reviewed publications, demonstrating their reliability and relevance in translational research.
Webinar Overview
If you’ve made it this far, your study is likely entering the in vivo stage—an exciting yet critical phase in drug development. However, without strategic planning, this phase can lead to delays and increased costs, compromising all the hard work you've put in so far.
Set your research up for success by mastering proven in vivo strategies that will streamline your path forward.
Join this webinar to learn how to:
Maximize data quality early to enhance decision-making and optimize compound selection before advancing to mammalian models
Reduce time loss and clinical failures due to common in vivo pitfalls
Align with the 3Rs principles for more efficient and ethical screenings
Webinar Overview
If you’ve made it this far, your study is likely entering the in vivo stage —an exciting yet critical phase in drug development. However, without strategic planning, this phase can lead to delays and increased costs, compromising all the hard work you've put in so far.
Set your research up for success by mastering proven in vivo strategies that will streamline your path forward.
Join this webinar to learn how to:
Maximize data quality early to enhance decision-making and optimize compound selection before advancing to mammalian models
Reduce time loss and clinical failures
due to common in vivo pitfalls
Align with the 3Rs principles for more efficient and ethical screenings
Privacy policy · Terms of Use · © 2024 ZeClinics